Ocular rosacea: Common and commonly missed

被引:44
|
作者
Vieira, Ana Carolina [1 ]
Mannis, Mark J. [2 ]
机构
[1] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil
[2] Univ Calif Davis, Hlth Syst Eye Ctr, Dept Ophthalmol, Davis, CA USA
关键词
biomarker; conjunctivitis; disease triggers; ocular rosacea; rosacea; saliva; tear break-up time; tear fluid; TEAR FLUID; INFLAMMATORY CYTOKINES; HELICOBACTER-PYLORI; ACNE ROSACEA; MANAGEMENT; SUBTYPE; CLASSIFICATION; CONJUNCTIVITIS; CYCLOSPORINE; PATHOGENESIS;
D O I
10.1016/j.jaad.2013.04.042
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Rosacea is a prevalent disorder that may be disfiguring and cause significant ocular morbidity, if not diagnosed and managed appropriately. Ocular rosacea, in particular, is often left undiagnosed as no specific test is available to confirm the diagnosis. Accurate diagnosis is further complicated because symptoms of ocular rosacea are not always specific to the disorder alone. Other ophthalmic disorders may present with similar findings. Further challenges exist because the severity of ocular symptoms is often not related to the severity of cutaneous findings in rosacea. Isolating a disease marker may facilitate earlier diagnosis and treatment, and could also contribute to better understanding of disease pathogenesis. The glycomics of tear fluid and saliva in patients with rosacea shows promise as an initial step in the search for a biomarker specific to the disease. We have previously found potentially important disease biomarkers in roseatic tear and saliva samples. Further investigation should prove important in the early stages of developing a set of markers for accurate disease identification.
引用
收藏
页码:S36 / S41
页数:6
相关论文
共 50 条
  • [21] Topical Azithromycin as a Novel Treatment for Ocular Rosacea
    Mantelli, Flavio
    Di Zazzo, Antonio
    Sacchetti, Marta
    Dianzani, Caterina
    Lambiase, Alessandro
    Bonini, Stefano
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2013, 21 (05) : 371 - 377
  • [22] Evaluation of Ocular and Systemic Oxidative Stress Markers in Ocular Rosacea Patients
    Yesilirmak, Nilufer
    Bukan, Neslihan
    Kurt, Busra
    Yuzbasioglu, Sema
    Zhao, Min
    Rodrigues-Braz, Daniela
    Aktas, Akin
    Behar-Cohen, Francine
    Bourges, Jean-Louis
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (13)
  • [23] Treatment of pediatric ocular rosacea: A systematic review
    Khaslavsky, S.
    Starkey, S. Y.
    Avraham, S.
    Kashetsky, N.
    Mukovozov, I.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (03): : 199 - 201
  • [24] Efficacy of topical cyclosporine for the treatment of ocular rosacea
    Barry A. Schechter
    Randy S. Katz
    Lee S. Friedman
    Advances in Therapy, 2009, 26 : 651 - 659
  • [25] Impression cytology and ocular characteristics in ocular rosacea
    Koçak-Altintas, AG
    Kocak-Midillioglu, I
    Gül, U
    Bilezikci, B
    Isiksaçan, O
    Duman, S
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2003, 13 (04) : 351 - 359
  • [26] Group IIA phospholipase A2 concentration of tears in patients with ocular rosacea
    Kari, O
    Aho, VV
    Peltonen, S
    Saari, JM
    Kari, M
    Mäâttä, M
    Collan, Y
    Saari, KM
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2005, 83 (04): : 483 - 486
  • [27] Ocular and cutaneous rosacea in a child
    Di Matteo, Maria C.
    Stefano, Paola C.
    Cirio, Ana
    Lopez, Beatriz
    Centeno, Maria
    Bocian, Marcela
    Cervini, Andrea B.
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (02): : E170 - E172
  • [28] Rosacea fulminans with ocular involvement
    Kim, T. G.
    Noh, S. M.
    Do, J. E.
    Lee, M. G.
    Oh, S. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (04) : 877 - 879
  • [29] An unusual presentation of ocular rosacea
    Celiker, Hande
    Toker, Ebru
    Ergun, Tulin
    Cinel, Leyla
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2017, 80 (06) : 396 - 398
  • [30] Dendritic keratopathy in ocular rosacea
    Lee, WB
    Darlington, JK
    Mannis, MJ
    Schwab, IR
    CORNEA, 2005, 24 (05) : 632 - 633